Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive IV insulin versus conventional therapy in acute coronary syndrome with hyperglycemia
NL-OMON32341Active, not recruiting
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human insulin in acute coronary syndrome (ACS), myocardial infarction (MI) and hyperglycemia (2 arms), sponsored by Noordwest Ziekenhuisgroep. Primary endpoint: Troponin T level at 72 hours. Started Jul 2008; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
acute coronary syndrome (ACS)myocardial infarction (MI)hyperglycemia
Beyond the preview
Go deeper on NL-OMON32341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32341.